Capuano, I.;                     Buonanno, P.;                     Riccio, E.;                     Bianco, A.;                     Pisani, A.    
        Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis. J. Clin. Med. 2022, 11, 6184.
    https://doi.org/10.3390/jcm11206184
    AMA Style
    
                                Capuano I,                                 Buonanno P,                                 Riccio E,                                 Bianco A,                                 Pisani A.        
                Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis. Journal of Clinical Medicine. 2022; 11(20):6184.
        https://doi.org/10.3390/jcm11206184
    
    Chicago/Turabian Style
    
                                Capuano, Ivana,                                 Pasquale Buonanno,                                 Eleonora Riccio,                                 Antonio Bianco,                                 and Antonio Pisani.        
                2022. "Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis" Journal of Clinical Medicine 11, no. 20: 6184.
        https://doi.org/10.3390/jcm11206184
    
    APA Style
    
                                Capuano, I.,                                 Buonanno, P.,                                 Riccio, E.,                                 Bianco, A.,                                 & Pisani, A.        
        
        (2022). Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis. Journal of Clinical Medicine, 11(20), 6184.
        https://doi.org/10.3390/jcm11206184